FindTrial
Sign In

Phacoemulsification versus Phacoemulsification combined with Intracameral Triamcinolone Acetonide to Prevent Intraocular Pressure Rise after Acute Angle Closure Crisis: a prospective randomized controlled trial

Phacoemulsification versus Phacoemulsification combined with Intracameral Triamcinolone Acetonide to Prevent Intraocular Pressure Rise after Acute Angle Closure Crisis: a prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013849
Enrollment
Unknown
Registered
2017-12-11
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

:phacoemulsification + intraocular lens implantation + Separation of anterior chamber angle adhesion
B group:Phacoemulsification combined with goniosynechialysis+injection of triamcinolone acetonide on anterior chamber

Sponsors

Beijing TongRen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patient with acute anterior chamber angle closure crisis

Exclusion criteria

Exclusion criteria: any known allergy to ercaine, or triamcinolone suspension.

Design outcomes

Primary

MeasureTime frame
eye presure;—

Countries

China

Contacts

Public ContactNingli Wang

Beijing TongRen Hosipital

wningli@vip.163.com+86 010-58265922

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026